Datavant: sourced choices

20 product and go-to-market choices, oldest first. Back to the case study

2017-09-20Product · Initial product direction The launch proposed applying AI to clinical-trial data and drug-development decisions. DV1
2017-09-20Go_To_Market · Venture formation Roivant launched Datavant with Travis May as its leader. DV1
2018-04-27Product · Patient linkage The product connected records concerning the same patient across datasets. DV2
2018-04-27Product · Data permissions The offering included tools for controlling data access and permissions. DV2
2018-04-27Product · Data discovery The company supplied tools to help institutions discover relevant datasets. DV2
2018-04-27Go_To_Market · Data-owner customer Datavant sold tools to institutions seeking to connect and share datasets. DV2
2018-04-27Go_To_Market · Partner boundary The company positioned its products as infrastructure for outside analytics companies. DV2
2021-06-09Product · De-identification The initial connectivity business supported exchange of de-identified data for analysis. DV3
2021-06-09Go_To_Market · Neutrality commitment May stated that Datavant would neither monetize data nor perform analytics. DV3
2021-06-09Go_To_Market · Combination financing Existing and new financial investors backed the announced Ciox combination. DV4
2021-07-28Product · Switchboard The merged company launched Switchboard for controlled health-data exchange. DV5
2021-07-28Go_To_Market · Acquisition route Datavant completed its merger with the provider-facing record-exchange company Ciox. DV5
2022-04-20Product · Digital release Switchboard supported digital request submission, retrieval and delivery of records. DV6
2022-04-20Product · Patient authorization The April 2022 release announced: The digital patient request workflow included consent and authentication. DV6
2022-04-20Product · Provider configuration The April 2022 release announced: Providers could configure release rules by request type. DV6
2022-04-20Go_To_Market · Existing customer rollout Ciox offered Switchboard to interested customers of its release-of-information service. DV6
2022-04-20Go_To_Market · Customer control Additional use cases required provider consent. DV6
2025-05-15Go_To_Market · Cloud distribution Datavant Connect used AWS Clean Rooms for data discovery and evaluation. DV8
2025-07-11Product · Evidence platform The completed Aetion acquisition added real-world evidence technology and scientific services. DV9
2025-07-11Go_To_Market · Life sciences expansion Aetion joined Datavant’s Life Sciences business after the acquisition closed. DV9